Newsroom

ARCHIVED: Delaying chemotherapy in breast cancer patients reduces overall survival, especially for those with triple-negative breast cancer

December 10, 2015

MD Anderson study identifies socio-demographic factors contributing to delayed treatment

MD Anderson News Release 12/10/2015

Postponing the start of adjuvant chemotherapy for more than 90 days following surgery may significantly increase risk of death for breast cancer patients, particularly those with triple-negative breast cancer (TNBC), according to a new study from The University of Texas MD Anderson Cancer...

ARCHIVED: Everolimus improves progression-free survival for patients with advanced, nonfunctional neuroendocrine tumors of the lung, gastrointestinal tract

BY Tyler Hill

September 26, 2015

MD Anderson led research in field, from small investigator-initiated studies to international confirmatory trials

MD Anderson News...

ARCHIVED: Breakthrough study demonstrates survival advantage with immune checkpoint inhibitor for advanced kidney cancer patients

BY Tyler Hill

September 25, 2015

CheckMate-025 study led by The University of Texas MD Anderson Cancer Center portends paradigm change in standard of care treatment...

ARCHIVED: MD Anderson study identifies leukemia tumor suppressor

September 24, 2015

Protein-coding gene hnRNP K may be culprit in acute myeloid leukemia

MD Anderson News Release 09/24/2015

A protein-coding gene called hnRNP K has been identified as a tumor suppressor for acute myeloid leukemia (AML), a finding that could be important for investigating how best to target treatment of a blood cancer striking mostly older individuals.

Expression of the protein-coding gene hnRNP K is significantly...